These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22570295)

  • 21. Correction of iron deficiency anaemia using IV CosmoFer in CKD patients with asthma: a prospective study.
    Syed A; Bhandari S
    QJM; 2016 Mar; 109(3):187-90. PubMed ID: 26101227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective study of the safety and efficacy of low molecular weight iron dextran for children with iron deficiency anemia.
    Boucher AA; Bedel A; Jones S; Lenahan SF; Geer R; McGann PT
    Pediatr Blood Cancer; 2021 Jul; 68(7):e29024. PubMed ID: 33769677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of intravenous iron supplementation in chronic kidney disease: an update.
    Macdougall IC; Geisser P
    Iran J Kidney Dis; 2013 Jan; 7(1):9-22. PubMed ID: 23314137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parenteral iron dextran therapy: a review.
    Burns DL; Mascioli EA; Bistrian BR
    Nutrition; 1995; 11(2):163-8. PubMed ID: 7647482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of available intravenous iron preparations in hemodialysis.
    Palmer K; Cameron K; Battistella M
    CANNT J; 2013; 23(2):51-4; quiz 55-6. PubMed ID: 24069699
    [No Abstract]   [Full Text] [Related]  

  • 26. Parenteral iron therapy in the treatment of iron deficiency anemia during pregnancy: a randomized controlled trial.
    Tariq N; Ayub R; Khan WU; Ijaz S; Alam AY
    J Coll Physicians Surg Pak; 2015 Mar; 25(3):193-7. PubMed ID: 25772960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients.
    Auerbach M; Winchester J; Wahab A; Richards K; McGinley M; Hall F; Anderson J; Briefel G
    Am J Kidney Dis; 1998 Jan; 31(1):81-6. PubMed ID: 9428456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
    Fishbane S; Frei GL; Maesaka J
    Am J Kidney Dis; 1995 Jul; 26(1):41-6. PubMed ID: 7611266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity of parenteral iron dextran therapy.
    Burns DL; Pomposelli JJ
    Kidney Int Suppl; 1999 Mar; 69():S119-24. PubMed ID: 10084295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis.
    Fishbane S; Wagner J
    Am J Kidney Dis; 2001 May; 37(5):879-83. PubMed ID: 11325667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
    Qunibi WY
    Arzneimittelforschung; 2010; 60(6a):399-412. PubMed ID: 20648931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematologic and erythropoietin responses to iron dextran in the hemodialysis environment.
    Senger JM; Weiss RJ
    ANNA J; 1996 Jun; 23(3):319-23; discussion 324-5. PubMed ID: 8716991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous iron infusion and newer non-dextran formulations.
    Aung T; Coleman J; Davidson PW; Hetzel DJ; Aung ST
    N Z Med J; 2021 Apr; 134(1534):118-127. PubMed ID: 33927444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of intravenous iron dextran (Dexferrum) during hemodialysis in patients with end stage renal disease.
    Hood SA; O'Brien M; Higgins R
    Nephrol Nurs J; 2000 Feb; 27(1):41-2. PubMed ID: 10852689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: a double blind randomized trial.
    Auerbach M; Chaudhry M; Goldman H; Ballard H
    J Lab Clin Med; 1998 Mar; 131(3):257-60. PubMed ID: 9523850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.
    Faich G; Strobos J
    Am J Kidney Dis; 1999 Mar; 33(3):464-70. PubMed ID: 10070910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
    Anirban G; Kohli HS; Jha V; Gupta KL; Sakhuja V
    Ren Fail; 2008; 30(6):629-38. PubMed ID: 18661414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
    Bhandari S; Naudeer S
    J Eval Clin Pract; 2008 Dec; 14(6):996-1001. PubMed ID: 18785894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical update: intravenous iron for anaemia.
    Auerbach M; Ballard H; Glaspy J
    Lancet; 2007 May; 369(9572):1502-1504. PubMed ID: 17482969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.